Total Payments
$1,951
2024 Payments
$98.71
Companies
22
Transactions
87
Medicare Patients
3,018
Medicare Billing
$285,645
Payment Breakdown by Category
Food & Beverage$1,951 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,951 | 87 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $343.57 | 20 | $0 (2022) |
| ABBVIE INC. | $287.32 | 17 | $0 (2024) |
| GlaxoSmithKline, LLC. | $243.69 | 11 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $219.01 | 10 | $0 (2024) |
| Abbott Laboratories | $184.87 | 4 | $0 (2023) |
| Amarin Pharma Inc. | $87.73 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $82.04 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $76.94 | 1 | $0 (2017) |
| Allergan, Inc. | $72.30 | 5 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $63.54 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.71 | 5 | ABBVIE INC. ($30.08) |
| 2023 | $172.19 | 6 | Abbott Laboratories ($102.42) |
| 2022 | $191.60 | 8 | Lundbeck LLC ($63.50) |
| 2021 | $356.64 | 18 | Abbott Laboratories ($82.45) |
| 2020 | $214.74 | 13 | AstraZeneca Pharmaceuticals LP ($68.50) |
| 2019 | $81.28 | 6 | GlaxoSmithKline, LLC. ($15.05) |
| 2018 | $223.01 | 10 | PFIZER INC. ($118.33) |
| 2017 | $613.20 | 21 | AbbVie, Inc. ($95.15) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Athena Bioscience, LLC | NEXICLON XR (Drug) | Food and Beverage | Cash or cash equivalent | $28.44 | General |
| Category: CARDIOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 11/01/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Diabetes Care | ||||||
| 09/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: Diabetes Care | ||||||
| 02/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $63.50 | General |
| Category: NEUROLOGY | ||||||
| 05/31/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/12/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: PRIMARY CARE | ||||||
| 04/11/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: RESPIRATORY | ||||||
| 01/31/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $70.67 | General |
| Category: Diabetes Care | ||||||
| 10/08/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Diabetes Care | ||||||
| 10/04/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/07/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $15.57 | General |
| Category: Neurology | ||||||
| 08/31/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 561 | 1,686 | $121,950 | $56,421 |
| 2022 | 12 | 645 | 1,937 | $143,655 | $64,407 |
| 2021 | 15 | 835 | 2,313 | $171,725 | $83,323 |
| 2020 | 14 | 977 | 2,378 | $189,555 | $81,495 |
Total Patients
3,018
Total Services
8,314
Medicare Billing
$285,645
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 469 | $70,350 | $35,035 | 49.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 256 | $25,600 | $13,606 | 53.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 138 | 348 | $3,480 | $2,877 | 82.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $2,700 | $2,164 | 80.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 212 | $6,360 | $1,958 | 30.8% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 12 | 13 | $845.00 | $409.06 | 48.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 40 | 83 | $1,245 | $182.60 | 14.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 97 | $1,940 | $110.14 | 5.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 22 | 100 | $5,500 | $33.88 | 0.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 42 | $1,050 | $27.38 | 2.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 13 | 48 | $2,880 | $18.37 | 0.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 153 | 572 | $85,800 | $42,940 | 50.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 304 | $30,400 | $16,206 | 53.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 66 | 201 | $6,030 | $1,758 | 29.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $1,800 | $1,488 | 82.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 142 | 392 | $3,920 | $1,148 | 29.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 13 | $845.00 | $422.38 | 50.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 37 | 55 | $825.00 | $121.74 | 14.8% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2022 | 11 | 11 | $660.00 | $119.71 | 18.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 13 | 65 | $1,300 | $67.48 | 5.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 17 | 141 | $4,440 | $52.92 | 1.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 24 | 59 | $1,475 | $44.28 | 3.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 31 | 112 | $6,160 | $38.69 | 0.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 194 | 718 | $107,700 | $56,281 | 52.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 133 | 268 | $26,800 | $16,018 | 59.8% |
About Dr. Ralph Simms, DO
Dr. Ralph Simms, DO is a Family Medicine healthcare provider based in Glen Daniel, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124146113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Simms, DO has received a total of $1,951 in payments from pharmaceutical and medical device companies, with $98.71 received in 2024. These payments were reported across 87 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,951).
As a Medicare-enrolled provider, Simms has provided services to 3,018 Medicare beneficiaries, totaling 8,314 services with total Medicare billing of $285,645. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties General Practice
- Location Glen Daniel, WV
- Active Since 03/27/2007
- Last Updated 07/18/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1124146113
Products in Payments
- VRAYLAR (Drug) $247.43
- ELIQUIS (Drug) $188.57
- TRELEGY ELLIPTA (Drug) $157.49
- FARXIGA (Drug) $118.06
- EUCRISA (Drug) $109.42
- FREESTYLE LIBRE 2 (Device) $102.42
- Androgel (Drug) $95.15
- Vascepa (Drug) $87.73
- FreeStyle Libre 2 (Device) $82.45
- XARELTO (Drug) $82.04
- ANORO ELLIPTA (Drug) $72.71
- VYEPTI (Biological) $63.50
- BREZTRI AEROSPHERE (Drug) $50.72
- CHANTIX (Drug) $47.04
- ENTRESTO (Drug) $46.12
- LYRICA (Drug) $43.16
- Dayvigo (Drug) $37.04
- SYMBICORT (Drug) $33.99
- NEXICLON XR (Drug) $28.44
- CAPLYTA (Drug) $23.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.